Patient possibly cured of HIV infection by special stem-cell transplant

A patient living with HIV who received a blood stem cell transplant for high-risk acute myeloid leukemia has been free of the virus for 14 months after stopping HIV antiretroviral drug treatment, suggesting a cure, according to the Weill Cornell Medicine and New York-Presbyterian physician-scientists who performed the transplant and managed her care.

$9.8M NIH Grant drives clinical research into long COVID

Weill Cornell Medicine has been awarded a $9.8 million grant from the National Institutes of Health to lead a consortium of health care institutions that are analyzing nationwide health data in an effort to unravel the complexities of long COVID.

Study finds gut fungi influence neuroimmunity, behavior

A specific group of fungi residing in the intestines can protect against intestinal injury and influence social behavior, according to new preclinical research by scientists at Weill Cornell Medicine.

Lund Debate examines migration, global public health

This year’s Lund Critical Debate, “Migration in the Age of Pandemics,” on February 16 will explore ways to promote the best public health outcomes worldwide and protect human rights, as waves of people cross national borders.

Volunteer scientists change opinions about vaccines

Vaccination Conversations with Scientists, a group of more than 100 Cornell scientist volunteers educating the public about vaccines, is reporting success in shifting unvaccinated people’s beliefs about the shots.

Existing drug may protect against COVID lung injury

An FDA-approved drug that has been in clinical use for more than 70 years may protect against lung injury in severe COVID-19 cases, according to a preclinical study from researchers at Weill Cornell Medicine and Cold Spring Harbor Laboratory.

Versatile new pipeline enables study of gut bacteria

Scientists at Weill Cornell Medicine have developed a pipeline that will enable study of the biological roles of gut bacteria, recognized as key factors in health and disease.

Key growth factor protects gut from IBD

A growth factor protein produced by rare immune cells in the intestine can protect against the effects of inflammatory bowel disease, according to a new discovery from Weill Cornell Medicine researchers.

Researchers find key blood stem cell regulator

According to new research out of Weill Cornell Medicine, a protein that masterminds the way DNA is wrapped within chromosomes has a major role in the healthy functioning of blood stem cells, which produce all blood cells in the body.